You are here
DIAGNOLOGIX, LLC
https://www.diagnologix.com
UEI: FLYEKQS2YLE7
# of Employees: 6
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
Toward GMP production of antigen specific regulatory T cells
Amount: $2,000,000.00ABSTRACT There is an unmet need for more selective and sustainable therapeutics to treat a growing number of immune- related diseases. For example, autoimmune disorders affect more than 50 million pat ...
SBIRPhase II2022Department of Health and Human Services National Institutes of Health -
Toward GMP production of antigen specific regulatory T cells
Amount: $400,003.00ABSTRACT There is an unmet need for more selective and sustainable therapeutics to treat a growing number of immune- related diseases. For example, autoimmune disorders affect more than 50 million pat ...
SBIRPhase I2021Department of Health and Human Services National Institutes of Health -
TOPIC 360: A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER- MOONSHOT
Amount: $2,000,000.00Chemotherapy may control but rarely cure metastatic cancersRemarkablymodern immunotherapiesincluding cell based therapieshave cured metastatic melanomas and other types of cancersA major challenge for ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
TOPIC 360: A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER
Amount: $50,000.00Chemotherapy may control but rarely cure metastatic cancers. Remarkably, modern immunotherapies, including cell-based therapies, have cured metastatic melanomas and other types of cancers. A major cha ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
AN INNOVATIVE SYSTEM FOR CORD BLOOD STEM CELL ISOLATION
Amount: $1,500,000.00Umbilical cord bloodUCBhas been an alternative source for patients with hematologic diseases who may be potentially cured by allogeneic hematopoietic cell transplantationIn additionUCB is an important ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
An Innovative system for cord blood stem cell isolation
Amount: $149,999.00DESCRIPTION provided by applicant Substitution of abnormal stem cells with healthy cells has been accomplished clinically through hematopoietic stem cell HSC transplantation for more than year ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Buoyancy based bioseparations
Amount: $1,025,000.00DESCRIPTION provided by applicant The goal of the proposed work is to develop a simple robust and cost efficient circulating tumor cell CTC isolation system based on an innovative BUBLES BUoy ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
The Development of TLR Antagonists for Therapy of Hepatic Fibrosis and Cirrhosis
Amount: $143,649.00Abstract There is an unmet need for cost-efficient technologies for high purity isolation of rare circulating tumor cells (CTCs) from blood. An ideal isolation technique should be able to meet the fol ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health
